Findings showed ‘significant improvement in self-reported pain levels’ in former professional athletes with chronic pain.
Reports from Germany indicate that the draft law could include decriminalisation and cultivation for personal use.
As new findings emerge, what do we know about cannabis and diabetes so far?
The UK is poised to become Europe’s second largest medical cannabis market this year.
Recent studies find CBD may help curb opioid cravings and enhance the effects of the opioid antidote, naloxone.
A new case study highlights the potential of cannabis for improving quality of life in patients with neuropathic pain.
The Cannabis Industry Council (CIC), has called on the ACMD to recommend to the Home Office that cannabis be rescheduled for research purposes.
Advocates in the UK are calling for their own government to follow suit and invest in much-needed NHS trials.
One in two patients were prescribed medicinal cannabis for chronic pain, with a quarter taking it to treat mental health conditions.
Researchers identified a ‘significant decrease’ in financial interactions between opioid manufacturers and physicians as an effect of medical cannabis legalisation.